Exposure of PAD leads to activation of GSK3β, which in turn inhibits anterograde FAT by phosphorylating light chain subunits of kinesin-1 (Morfini et al., 2002; Kanaan et al., 2011). The gene discussed is GSK3B; the disease is peripheral arterial disease.